CLINICAL_TRIALS
trial_result
· 2023-02-14
Clinical Trial Update: A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures [Phase 3]
Summary
Open-label extension study of ganaxolone in drug-resistant partial-onset seizures; terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marinus Pharmaceuticals | Conditions: Drug Resistant Partial Onset Seizure | Phase 3 | Status: TERMINATED | Results posted: 2023-02-14